Karah Hila
SEC insider (Form 3/4/5 filer). CIK 0001668116. Director at DarioHealth Corp. (DRIO) and 1 other issuer. 7 reported Form 4/5 transactions since Sep 2024; latest on Sep 24, 2026. Located in NEW YORK, NY.
Companies Karah Hila has filed insider reports for
- DarioHealth Corp. (DRIO): Director
- Indaptus Therapeutics, Inc. (INDP): Director
Karah Hila
CIK: 0001668116
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Sep 24, 2026DRIO
DarioHealth Corp.
AwardDirect28K shares- - Sep 11, 2025DRIO
DarioHealth Corp.
AwardDirect20K shares- - Jun 10, 2025INDP
Indaptus Therapeutics, Inc.
AwardDirectStock Option (right to buy)
12.5K shares- - Apr 10, 2025INDP
Indaptus Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
250 shares at avg. $0.39- - Apr 10, 2025INDP
Indaptus Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
500 shares at avg. $0.39- - Apr 10, 2025INDP
Indaptus Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
250 shares at avg. $0.39- - Apr 10, 2025INDP
Indaptus Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
281 shares at avg. $0.39-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 24, 2026 |  DRIO DarioHealth Corp. | Award | 28,000 | - | $0 | Direct |
| Sep 11, 2025 | DRIO DarioHealth Corp. | Award | 20,000 | - | - | Direct |
| Jun 10, 2025 |  INDP Indaptus Therapeutics, Inc. | Award Stock Option (right to buy) | 12,500 | - | - | Direct |
| Apr 10, 2025 | INDP Indaptus Therapeutics, Inc. | Disposition Stock Option (right to buy) | 250 | $0.39 | - | Direct |
| Apr 10, 2025 | INDP Indaptus Therapeutics, Inc. | Disposition Stock Option (right to buy) | 500 | $0.39 | - | Direct |
| Apr 10, 2025 | INDP Indaptus Therapeutics, Inc. | Disposition Stock Option (right to buy) | 250 | $0.39 | - | Direct |
| Apr 10, 2025 | INDP Indaptus Therapeutics, Inc. | Disposition Stock Option (right to buy) | 281 | $0.39 | - | Direct |
1-7 of 7 transactions